Nalini Murdter

JSR Life Sciences has appointed Nalini Murdter as president and CEO of MBL International (MBLI), a JSR subdivision that provides products for life sciences research and clinical diagnostics, specializing in reagents and assays for detecting biomarkers and analyzing disease pathways. Murdter previously served as vice president of commercial operations and business development at MBLI, and managing director of the diagnostics and research products division at JSR. She was previously chief business offices a NanoString Technologies, and held several senior management positions in business development, strategy, and marketing at Agilent Technologies.